Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MW

Michael Wittekind — 27 Patents

COContrafect: 11 patents #1 of 13Top 8%
Bristol-Myers Squibb: 9 patents #586 of 3,969Top 15%
AMAmgen: 3 patents #1,002 of 2,867Top 35%
TBTrellis Bioscience: 2 patents #21 of 28Top 75%
ABA-Alpha Bio: 1 patents #8 of 10Top 80%
SFSUNY Research Foundation: 1 patents #985 of 355Top 280%
New Canaan, CT: #8 of 268 inventorsTop 3%
Connecticut: #1,328 of 34,797 inventorsTop 4%
Overall (All Time): #142,059 of 4,157,543Top 4%
27 Patents All Time
Michael Wittekind has been granted 27 US patents while listed as an inventor at Contrafect. The first was granted in 2001 and the most recent in December 2025. Michael Wittekind ranks #142,059 of 4,157,543 US inventors in our database (top 3.4%). Patent records list Michael Wittekind in New Canaan, CT, US.

Patents per Year

Patents granted per year, 2001 to 2024Bar chart with a peak of 5 patents in 2022.peak 52001: 1 patents20012004: 1 patents2010: 2 patents20102012: 2 patents2013: 3 patents20132016: 2 patents2017: 1 patents20172018: 2 patents2020: 3 patents20202021: 1 patents2022: 5 patents20222023: 2 patents2024: 1 patents2024

Issued Patents All Time

Showing 1–25 of 27 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12491245 Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof Angeles Estelles, Lawrence M. Kauvar, Adam Vigil 2025-12-09
12144845 Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby Raymond Schuch 2024-11-19
11827693 Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy Adam Vigil 2023-11-28
11726097 Methods for characterizing and engineering protein-protein interactions David Younger, David Colby, Randolph Lopez 2023-08-15
11524046 Biofilm prevention, disruption and treatment with bacteriophage lysin Raymond Schuch, Robert C. Nowinski, Babar Khan, Jimmy Andrew Rotolo 2022-12-13 $135,000
11474111 Methods for characterizing and engineering protein-protein interactions David Younger, David Colby, Randolph Lopez 2022-10-18
11413334 Lysin polypeptides active against Gram-negative bacteria Raymond Schuch, Simon Hoffenberg 2022-08-16 $336,000
11357833 Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby Raymond Schuch 2022-06-14 $2,310,000
11246928 Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof Angeles Estelles, Lawrence M. Kauvar, Adam Vigil 2022-02-15 $2,066,000
10995131 Libraries of modified fibronectin type III tenth domain-containing polypeptides Yan Chen, Elena Getmanova, Martin C. Wright, Alan S. Harris, Ai Ching Lim +2 more 2021-05-04
10813983 Bacteriophage lysin and antibiotic combinations against gram positive bacteria Raymond Schuch, Robert C. Nowinski, Han Lee, Brent Schneider 2020-10-27 $3,995,000
10744189 Lysin polypeptides active against Gram-negative bacteria Raymond Schuch, Simon Hoffenberg 2020-08-18 $3,990,000
10639370 Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof Angeles Estelles, Lawrence M. Kauvar, Adam Vigil 2020-05-05 $2,821,000
9889181 Bacteriophage lysin and antibiotic combinations against gram positive bacteria Raymond Schuch, Robert C. Nowinski, Han Lee, Brent Schneider 2018-02-13 $2,046,000
9862758 Inhibitors of type 2 vascular endothelial growth factor receptors Yan Chen, Elena Getmanova, Martin C. Wright, Alan S. Harris, Ai Ching Lim +2 more 2018-01-09 $274,882,000
9718875 Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy Adam Vigil 2017-08-01 $1,134,000
9499594 Biofilm prevention, disruption and treatment with bacteriophage lysin Raymond Schuch, Robert C. Nowinski, Babar Khan, Jimmy Andrew Rotolo 2016-11-22 $1,695,000
9328157 Inhibitors of type 2 vascular endothelial growth factor receptors Yan Chen, Elena Getmanova, Martin C. Wright, Alan S. Harris, Ai Ching Lim +2 more 2016-05-03
8609613 Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides Yan Chen, Elena Getmanova, Martin C. Wright, Alan S. Harris, Ai Ching Lim +2 more 2013-12-17 $215,981,000
8592562 Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects Gunasekaran Kannan, Wei Yan, Martin J. Pentony 2013-11-26 $490,203,000
8460647 Pre-ligand assembly domain of the IL-17 receptor Sarah L. Gaffen, Fang Shen, Walter Hanel, Jill Kramer, James P. Malone +1 more 2013-06-11 $118,158,000
8324362 Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors Yan Chen, Elena Getmanova, Martin C. Wright, Alan S. Harris, Ai Ching Lim +2 more 2012-12-04 $36,752,000
8193322 Methods for generating monovalent IgG Wei Yan, Carla Forte 2012-06-05 $75,955,000
7858739 Inhibitors of type 2 vascular endothelial growth factor receptors Yan Chen, Elena Getmanova, Martin C. Wright, Alan S. Harris, Ai Ching Lim +2 more 2010-12-28 $67,782,000
7847062 Pharmacokinetic modulation and compositions for modified FN3 polypeptides Yan Chen, Elena Getmanova, Martin C. Wright, Alan S. Harris, Ai Ching Lim +2 more 2010-12-07 $49,606,000